+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID05916638

Role of Monocytes and Macrophages in Sarcoidosis and Tuberculosis to Study Granuloma Formation and Maintenance

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-03-03

100

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating sarcoidosis, a systemic inflammatory disease characterized by granuloma formation, which shares many features with tuberculosis. This study aims to understand the role of monocytes and macrophages in granuloma formation and maintenance by comparing patients with sarcoidosis to those with tuberculosis. The goal is to define a specific immune cell signature and explore factors contributing to chronic immune overactivation, potentially leading to new treatment approaches. Participants include patients diagnosed with sarcoidosis or tuberculosis. Blood samples will be collected to analyze immune cell signatures using various advanced laboratory methods such as flow cytometry, RNA sequencing, and epigenetic studies. These analyses will occur at diagnosis and during follow-up visits at 0, 6, and 12 months. The study also examines tissue samples to understand granuloma structure and immune cell interactions. During the study, participants will provide blood and tissue samples at defined intervals for detailed laboratory tests including cytokine levels, transcriptomic, and epigenomic analyses. Researchers will monitor immune cell activation over up to 12 months to identify differences between sarcoidosis and tuberculosis. This observational study involves no treatment intervention, focusing instead on understanding disease mechanisms and identifying potential diagnostic markers or therapeutic targets.

CONDITIONS

Brief Title

MoMa Signature During Granulomatosis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male and female participants over 18 years old
  • Diagnosed with sarcoidosis or tuberculosis
  • Affiliated with medical insurance
Not Eligible

You will not qualify if you...

  • HIV infection
  • Pregnant or breastfeeding women
  • Under legal protection, guardianship, or curatorship
  • Absence of signed consent
  • Other granulomatous diseases ultimately identified instead of sarcoidosis or tuberculosis

Research Team

K

Karim Sacre, MD-PhD, PU-PH

D

Darragh DUFFY, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here